Vital Signs - Lucrative Therapeutic Markets: Opportunities, Challenges and Future Outlook
Vital Signs - Lucrative Therapeutic Markets: Opportunities, Challenges and Future Outlook
RELEASE DATE
31-Mar-2008
31-Mar-2008
REGION
North America
North America
Research Code: 9561-00-5B-00-00
SKU: HC00522-NA-MR_03994
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00522-NA-MR_03994
Description
This issue of Vital Signs, released on March 31, 2008, provides an strategic overview of selected lucrative market areas in the pharmaceutical industry. Additionally, a company spotlight is provided for Arena Pharmaceuticals, a clinical stage biopharmaceutical company focusing on developing innovative oral drugs for patients with serious diseases and disorders. Reimbursement and regulatory news from the FDA is also provided for the week of March 17 - March 21, 2008.
Table of Contents
This week's issue:
Popular Topics
This issue of Vital Signs, released on March 31, 2008, provides an strategic overview of selected lucrative market areas in the pharmaceutical industry. Additionally, a company spotlight is provided for Arena Pharmaceuticals, a clinical stage biopharmaceutical company focusing on developing innovative oral drugs for patients with serious diseases and disorders. Reimbursement and regulatory news from the FDA is also provided for the week of March 17 - March 21, 2008.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-5B-00-00 |
Is Prebook | No |